Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic

• Asıl Yazarlar: Chih-Wei Lin (Yazar), Yu-Ling Liang (Yazar), Ming-Ta Chuang (Yazar), Chun-Han Tseng (Yazar), Pei-Yin Tsai (Yazar), Mei-Tsz Su (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2023-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Paxlovid is an oral drug composed of nirmatrelvir and ritonavir that has been demonstrated to be effective in decreasing the risk of severe coronavirus disease 2019 (COVID-19). Here, we report the use of paxlovid in pregnant women with COVID-19. Methods: Pregnant women attending a tertia...